Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis.

导出 OA

翻译打印收藏纠错

作者： Marjolein S,de Bruin-Weller ^[1] ; Esther,Serra-Baldrich ^[2] ; Sebastien,Barbarot ^[3] ; Susanne,Grond ^[4] ; Christopher,Schuster ^[4] ; Helmut,Petto ^[4] ; Jean-Philippe,Capron ^[4] ; Afaf,Raibouaa ^[4] ; Thomas,Werfel ^[5]

作者单位： Department of Dermatology and Allergology, University Medical Center, Utrecht, The Netherlands. m.s.debruin-weller@umcutrecht.nl. ^[1] Department of Dermatology, Cutaneous Allergy Unit, Hospital Sant Pau, Universitat Autònoma Barcelona, Barcelona, Spain. ^[2] Department of Dermatology, Nantes Université, CHU Nantes, INRAE, UMR 1280 PhAN, 44000, Nantes, France. ^[3] Eli Lilly and Company, Indianapolis, IN, USA. ^[4] Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany. ^[5]

关键词 Atopic dermatitis Indirect treatment comparison Systemic therapies

DOI 10.1007/s13555-022-00734-w

PMID 35543919

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交